Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5327-45-7

Post Buying Request

5327-45-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5327-45-7 Usage

General Description

N-benzyloctadecanamide is a chemical compound that belongs to the class of amides and has the molecular formula C24H37NO. It consists of a long alkyl chain with a benzyl group attached to the nitrogen atom. N-benzyloctadecanamide is commonly used as an intermediate in the synthesis of various organic compounds, particularly in the production of pharmaceuticals and agrochemicals. It is also known for its potential biological activities, including anti-inflammatory and analgesic properties. N-benzyloctadecanamide has also been studied for its potential use in the treatment of skin disorders and as a local anesthetic. Overall, this compound has a wide range of applications in various fields, making it a versatile and important chemical in the industry.

Check Digit Verification of cas no

The CAS Registry Mumber 5327-45-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,2 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5327-45:
(6*5)+(5*3)+(4*2)+(3*7)+(2*4)+(1*5)=87
87 % 10 = 7
So 5327-45-7 is a valid CAS Registry Number.

5327-45-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-benzyloctadecanamide

1.2 Other means of identification

Product number -
Other names N-benzylstearamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5327-45-7 SDS

5327-45-7Synthetic route

stearic acid
57-11-4

stearic acid

benzyl azide
622-79-7

benzyl azide

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
With 2,2'-dipyridyldiselenide; trimethylphosphane In toluene at 0 - 20℃; Staudinger-Vilarrasa reaction; Inert atmosphere;94%
stearic acid
57-11-4

stearic acid

benzylamine
100-46-9

benzylamine

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
With Bromotrichloromethane; 4-(diphenylphosphino)-benzyltrimethylammonium bromide; triethylamine In tetrahydrofuran; dichloromethane at 60℃; for 6h; Inert atmosphere;93%
Stage #1: stearic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 2h;
Stage #2: benzylamine With dmap In dichloromethane at 20℃; for 18h;
85%
With nano-Fe3O4-supported sulfonic acid In neat (no solvent) at 120℃; for 2h; Green chemistry;76%
distearoyl diselenide
65212-12-6

distearoyl diselenide

benzylamine
100-46-9

benzylamine

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
In benzene at 25℃; for 0.166667h;88%
1-Pyrrol-1-yl-octadecan-1-one
86734-18-1

1-Pyrrol-1-yl-octadecan-1-one

benzylamine
100-46-9

benzylamine

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
In tetrahydrofuran for 16h; Heating;87%
In tetrahydrofuran for 16h; Product distribution; Heating;87%
Stearoyl chloride
112-76-5

Stearoyl chloride

benzylamine
100-46-9

benzylamine

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
With benzene
With dmap In dichloromethane at 25℃; for 2h;
stearamide
124-26-5

stearamide

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 72 percent / Amberlyst A-21 resin / acetonitrile / 16 h / 55 °C
2: 87 percent / tetrahydrofuran / 16 h / Heating
View Scheme
C36H50OSSi

C36H50OSSi

benzylamine
100-46-9

benzylamine

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
In 5,5-dimethyl-1,3-cyclohexadiene at 60℃; Inert atmosphere;120 mg
stearic acid
57-11-4

stearic acid

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (2,3,4,5,6-pentafluorophenyl)ammonium triflate / 5,5-dimethyl-1,3-cyclohexadiene / 2 h / Inert atmosphere; Reflux
2: 5,5-dimethyl-1,3-cyclohexadiene / 60 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: thionyl chloride / dichloromethane / 2 h / 25 °C
2: dmap / dichloromethane / 2 h / 25 °C
View Scheme
C25H50N2O2

C25H50N2O2

benzylamine
100-46-9

benzylamine

N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

Conditions
ConditionsYield
In water at 20℃; for 0.25h; Green chemistry;
N-benzyl-octadecanamide
5327-45-7

N-benzyl-octadecanamide

A

stearic acid
57-11-4

stearic acid

B

benzylamine
100-46-9

benzylamine

Conditions
ConditionsYield
mit UV-Licht.Irradiation;

5327-45-7Relevant articles and documents

Synthesis and biological screening of a library of macamides as TNF-α inhibitors

Apaza Ticona, Luis,Serban, Andreea Madalina,Acero Gómez, Javier,Rumbero Sánchez, ángel,Tena Pérez, Víctor

, p. 1196 - 1209 (2020/11/03)

Thirty-five macamide analogues were synthesised by modifying the initial molecular structure. The resulting structures were confirmed using NMR and MS. Cytotoxicity and the anti-inflammatory activity of these synthetic macamides were evaluated in the THP-1 cell line. Preliminary biological evaluation indicated that most of these synthetic macamides did not present cytotoxicity (MTT assay) in the tested cell line with respect to the control (actinomycin D). Regarding the anti-inflammatory activity, several analogues had a greater potential for inhibition of TNF-α than natural macamides. Synthetic macamide 4a was the most active (IC50 = 0.009 ± 0.001 μM) compared to the C87 (control). Through looking at the link between the chemical structure and the activity, our study proves that changes made to natural macamides at the level of the alkyl chain, the benzyl position, the amide bond, and the addition of two methyl groups to the aromatic ring (meta position) lead us to obtaining new macamides with greater anti-inflammatory activity. This journal is

Amidation and esterification of carboxylic acids with amines and phenols by N,N′-diisopropylcarbodiimide: A new approach for amide and ester bond formation in water

Fattahi, Nadia,Ayubi, Morteza,Ramazani, Ali

, p. 4351 - 4356 (2018/07/13)

The present study reports the successful synthesis of two important and abundant functional groups “ester and amide” by N,N′-diisopropylcarbodiimide (DIC) in water as a green solvent. A wide range of substrates could be employed with high functional group tolerance. The products were obtained in high yields after short reaction times. This method provides an efficient, economic, simple and very mild protocol for ester and amide bond formation in aqueous media. In addition, this work not only may lead to environmentally benign systems but also will provide a new aspect of organic chemistry in water.

Maca amide synthesis method and use thereof

-

Paragraph 0043-0045, (2017/09/12)

The invention relates to a synthetic method of MACAmide. The method includes following steps: with a fatty acid and benzylamine or m-methoxybenzylamine as reaction raw materials, mixing the raw materials in a dichloromethane solution in which HOAt, EDC.HCl and DIPEA are dissolved; performing a reaction with stirring; washing a reaction product with water; and drying a substance being undissolved in water to obtain the MACAmide. The method is simple in processes and the raw materials are easy to obtain. Operation conditions of the method are easy to control. The reaction product can reach a purity of 95% without purification. The invention provides basis for industrialized synthesis of the MACAmide. In addition, the MACAmide has effects of enhancing male reproductive ability and treating male sexual dysfunction. The invention provides market prospects to application of the MACAmide.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5327-45-7